Virological breakthrough is not a detrimental phenomenon in patients with compensated cirrhosis:: Results of a long term lamivudine therapy
56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Costa Rica, 11 - 15 November 2005, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- City: San-Francisco
- Country: Costa Rica
- Istanbul University Affiliated: Yes